Coya Therapeutics’ Development-and-License Deal with Dr. Reddy’s Laboratories

Lowenstein Sandler represented Coya Therapeutics in the transaction.Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced a development-and-license deal with Dr. Reddy’s Laboratories for its COYA…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now